Amarin | AMRN - EPS - Lucro por Ação

Preço das Ações
14.49
Mudança Diária
-0.51 -3.40%
Mensal
-7.29%
Anual
58.50%
Q1 Previsão
14.05




Eps Alterar Data
AbbVie USD 2.71 0.85 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.14 0.06 2025-12
AstraZeneca USD 2.12 0.26 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
DBV Technologies USD -0.24 1.31 2025-09
Esperion Therapeutics USD 0.26 0.42 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12